Summary
Diarrhoea and weight loss are found in more than 50% of patients with the acquired immunodeficiency syndrome (AIDS). In some patients the symptoms can be very severe, leading to death even in the absence of opportunistic infections. In 30% of these patients, enteric pathogens cannot be identified, and approximately only half of the identifiable aetiologic agents of diarrhoea in patients infected with the human immunodeficiency virus (HIV) were treatable with antibiotics. Immunoglobulins from bovine colostrum (Lactobin, Biotest, Dreieich, FRG) contain high titers of antibodies against a wide range of bacterial, viral and protozoal pathogens as well as against various bacterial toxins. Lactobin (LIG) is quite resistant to 24-h incubation with gastric juice. In a multi-center pilot study 37 immunodeficiency patients with chronic diarrhoea [29 HIV-infected patients, 2 patients with common variable immunodeficiency (CVID), one unidentified immunodeficiency, five patients with graft versus host disease (GvHD) following bone marrow transplantation] were treated with oral LIG (10 g/day for 10 days). Good therapeutic effects were observed. Out of 31 treatment periods in 29 HIV-infected patients 21 gave good results leading to transient (10 days) or long-lasting (more than 4 weeks) normalisation of the stool frequency. The mean daily stool frequency decreased from 7.4 to 2.2 at the end of the treatment. Eight HIV-infected patients showed no response. The diarrhoea recurred in 12 patients within 4 weeks (32.4%), while 19 patients were free of diarrhoea for at least 4 weeks (51.3%). In 5 patients intestinal cryptosporidiosis disappeared following oral LIG treatment. LIG treatment was also beneficial in 4 out of 5 GvHD patients. No serious side effects were recorded in any of the treated patients.
Article PDF
Similar content being viewed by others
Abbreviations
- AIDS:
-
acquired immunodeficiency syndrome
- ALL/3:
-
acute lymphoblastic leukaemia (FAB classification type 3)
- AML/1:
-
acute myeloblastic leukaemia (FAB classification type 1)
- CDC:
-
center of disease control
- CML/CP:
-
chronic myelocytic leukaemia (chronic phase)
- CMV:
-
cytomegalovirus
- CVID:
-
common variable immunodeficiency
- DHPG:
-
1,3-dihydroxy-2-propoxymethyl-guanine (gancyclovir)
- ELISA:
-
enzyme-linked immunosorbent assay
- GvHD:
-
graft versus host reaction
- HIV:
-
human immunodeficiency virus
- IgA:
-
immunoglobulin A
- IgG:
-
immunoglobulin G
- IgM:
-
immunoglobulin M
- INH:
-
isoniazid
- LIG:
-
Lactobin
- MAI:
-
mycobacterium avium intracellulare
- RAEB-T:
-
refractory anaemia with excess of blasts-transformation
- SD:
-
standard deviation
References
Barnes GL, Doyle WL, Hewson PH, Knoches AML, McLellan JA, Kitchen WH, Bishop RF (1982) A randomised trial of oral gammaglobulin in low birth weight infants infected with rotavirus. Lancet 19:1371–1373
Casemore DP, Sands RL, Curry A (1985) Cryptosporidium species; a “new” human pathogen. J Clin Pathol 38:1321–1336
Cello JP (1988) Gastrointestinal manifestations of HIV infections. In: Sande MA, Volberding PV (eds) Infectious disease clinics of North America. WB Saunders, Philadelphia, pp 387–396
Cone LA, Woodard DR, Potts BE, Byrd RG, Alexander RM, Last MD (1986) An update on the acquired immunodeficiency syndrome (AIDS). Associated disorders of the alimentary tract. Dis Colon Rectum 29:60–64
Conolly GM, Dryden MS, Shanson DC, Gazzard BG (1988) Cryptosporidial diarrhoea in AIDS and its treatment. Gut 29:593–597
Conolly GM, Shanson DC, Hawkins DA, Harcourt Webster JN, Gazzard BG (1989) Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut 30:195–200
Ebina T, Sato A, Umezu K, Ishida N, Ohyama S, Oizumi A, Aikawa K, Katagiri S, Katsushima N, Imai A, Kitaoka S, Suzuki H, Konno T (1985) Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody. Med Microbiol Immunol 174:177–185
Garcia LS, Bruckner DA, Brewer TC, Shimizu RY (1983) Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Micribiol 18:185–190
Heine J (1982) Eine einfache Nachweismethode für Kryptosporidien im Kot. Zentralbl Veterinärmed (B) 29:324–327
Henriksen SA, Pohlenz JFL (1981) Staining of cryptosporidia by modified Ziehl-Neelsen technique. Acta Vet Scand 22:594–596
Hilpert H, Gerber H, De Peyer E, Nusslé D (1974) Gastrointestinal passage of bovine anti-E. coli milk immunoglobulins (Ig) in infants. J Nestlè Res News (Lausanne) 75:134–139
Jacobs JL, Gold JWM, Murray HW (1985) Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:186–188
Kotler DP, Gaetz HP, Lange M, Klein EB, Holt P (1984) Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 101:412–428
Lasser KH, Lewin KJ, Ryning FW (1979) Cryptosporidial enteritis in a patient with hypogammaglobulinemia. Hum Pathol 10:234–240
Laughon BE, Druckman DA, Vernon A, Quinn TC, Polk BF, Modlin JF (1988) Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 94:984–993
Losonsky GA, Johnson JP, Winkelstein JA, Yolken RH (1985) Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. J Clin Invest 76:2362–2367
McClead RE, Gregory SA (1984) Resistance of bovine colostral anticholera toxin antibody to in vitro and in vivo proteolysis. Infect Immun 44:474–478
McClead R, Butler T (1988) Orally administered bovine colostral anti-cholera toxin antibodies: results of two clinical trials. Am J Med 85:811–816
Mietens C, Keinhorst H, Hilpert H, Gerber H, Amster H, Pahud JJ (1979) Treatment of infantile E. coli gastroenteritis with specific bovine anti E. coli milk immunoglobulins. Eur J Pediatr 132:239–252
Neter E (1956) Bacterial hemagglutination and hemolysis. Bact Rev 20:166–188
Pineiro A, Brock JH, Esparza I (1978) Isolation and properties of bovine colostral trypsin inhibitor. Ann Rech Vet 9:281–286
Präparate Information (1989) n-Imerleukin-2 Biotest/DRK Springe, April. Biotest Pharma, Frankfurt
Quinn TC, Stamm WE, Goodell SE (1983) The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med 309:576–582
Rham O de, Isliker H (1977) Proteolysis of bovine immunoglobulins. Int Arch Allergy Appl Immunol 55:61–69
Santangelo WC, Krejs GJ (1986) Gastrointestinal manifestations of the acquired immunodeficiency syndrome. Am J Med Sci 292:328–334
Serwadda D, Sewankambo N, Carswell JW, Bayley AC, Tedder RS, Weiss RA, Mugerwa R, Lwegaba A, Kirya GB, Downing RG, Clayden SA, Dalgleish AG (1985) Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet II: 849–852
Seto A, Okabe, Sasaki N, Ito Y (1976) Opsonic activity and O-agglutinins against Escherichia coli in bovine colostrum. Am J Vet Res 37:635–638
Sloper KS, Dourmashkin RR, Bird RB, Slavin G, Webster ADB (1982) Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Grit 23:80–82
Smith M (1988) Cows make antibodies against AIDS infections. N Sci 117:35
Smith PD, Lane HC, Gill VJ, Manischewitz JF, Quitman GV, Fauci AS (1988) Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med 108:328–333
Stephan W, Dichtelmüller H, Lissner R (1990) Antibodies from colostrum in oral immunotherapy. J Clin Chem Clin Biochem 28:19–23
Tacket CO, Losonsky GA, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM (1988) Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 318:1240–1243
Tzipori S, Roberton D, Chapman C (1986) Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J 293:1276–1277
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rump, J.A., Arndt, R., Arnold, A. et al. Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Investig 70, 588–594 (1992). https://doi.org/10.1007/BF00184800
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184800